The National Office of Animal Health (NOAH) has been elected to the board of AnimalhealthEurope, the European industry association representing manufacturers of veterinary medicines, vaccines and other animal health products.
NOAH chief executive, Dawn Howard said: “We are delighted to be rejoining the board of AnimalhealthEurope and to be part of shaping a proactive and forward-thinking agenda for animal health across the continent.
“Collaboration and shared ambition are more vital than ever as we face global challenges in disease prevention and sustainability.”
As part of this engagement, NOAH attended AnimalhealthEurope’s Annual Conference, held in Brussels, which this year focused on ‘Preventing Disease X: the value of investing in animal health’.
The event brought together industry leaders, policymakers, and veterinarians to explore how animal health investment can be integrated into wider efforts to prevent future pandemics.
Despite positive progress, such as shifting from reactive to preventative medicine over the past few decades, much remains to be done but the animal health industry is up for the challenge.
Mrs Howard added: “Preventing the next pandemic means investing in animal health, supporting veterinary infrastructure, and acknowledging the critical role that animals – both domesticated and wild – play in global health security.
“NOAH is committed to driving this agenda forward both in the UK and across Europe.”
